FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887016123> ?p ?o ?g. }

• W2887016123 endingPage "356" @default.
• W2887016123 startingPage "347" @default.
• W2887016123 abstract "Elinogrel is the only selective, competitive and reversible platelet P2Y(12) inhibitor available in both intravenous (IV) and oral formulations.This substudy of the Intravenous and Oral Administration of Elinogrel to Evaluate Tolerability and Efficacy in Nonurgent Percutaneous Coronary Intervention patients (INNOVATE-PCI) trial evaluated the pharmacokinetic and pharmacodynamic effects of two dosing regimens of IV followed by oral elinogrel (120 mg IV plus 100 mg oral twice daily; 120 mg IV plus 150 mg oral twice daily) versus standard clopidogrel therapy (300-600 mg oral loading dose plus 75 mg oral maintenance dose) in 56 patients undergoing nonurgent PCI. At time of randomization, 71.4% (40/56) of patients were using maintenance clopidogrel therapy. In the acute phase, an IV bolus of elinogrel achieved more rapid and potent antiplatelet effects compared with clopidogrel, which were sustained during the transition from the IV to the oral formulation in the first 24 hours of the peri-PCI period. During chronic therapy, elinogrel achieved similar levels of platelet reactivity compared with clopidogrel before the next oral dose and, although platelet reactivity was lower with elinogrel up to 6 hours after daily oral maintenance dosing, these differences were not statistically significant. These pharmacodynamic effects matched the pharmacokinetic profile of elinogrel. There were no differences in pharmacodynamic and pharmacokinetic effects between the two elinogrel dosing regimens.Compared with clopidogrel, the combination of IV and oral elinogrel achieves more rapid and enhanced antiplatelet effects that were sustained through the transition to oral elinogrel in the peri-PCI period, but these were not significant during chronic dosing in this pilot investigation.URL: http://www.clinicaltrials.gov. Unique identifier: NCT00751231." @default.
• W2887016123 created "2018-08-22" @default.
• W2887016123 creator A5000539924 @default.
• W2887016123 creator A5012918602 @default.
• W2887016123 creator A5012980712 @default.
• W2887016123 creator A5018963320 @default.
• W2887016123 creator A5023563685 @default.
• W2887016123 creator A5027684606 @default.
• W2887016123 creator A5030427600 @default.
• W2887016123 creator A5033408468 @default.
• W2887016123 creator A5034363730 @default.
• W2887016123 creator A5040418600 @default.
• W2887016123 creator A5043398153 @default.
• W2887016123 creator A5054604221 @default.
• W2887016123 creator A5060370891 @default.
• W2887016123 creator A5065650208 @default.
• W2887016123 creator A5068846586 @default.
• W2887016123 creator A5070006952 @default.
• W2887016123 creator A5085097521 @default.
• W2887016123 creator A5087089751 @default.
• W2887016123 date "2012-06-01" @default.
• W2887016123 modified "2023-09-23" @default.
• W2887016123 title "Pharmacokinetic and Pharmacodynamic Effects of Elinogrel" @default.
• W2887016123 cites W1553345686 @default.
• W2887016123 cites W168371622 @default.
• W2887016123 cites W1798325051 @default.
• W2887016123 cites W1966433445 @default.
• W2887016123 cites W1974591774 @default.
• W2887016123 cites W1986436930 @default.
• W2887016123 cites W1986455514 @default.
• W2887016123 cites W2001688139 @default.
• W2887016123 cites W2018383335 @default.
• W2887016123 cites W2041686781 @default.
• W2887016123 cites W2049447474 @default.
• W2887016123 cites W2053379248 @default.
• W2887016123 cites W2073399805 @default.
• W2887016123 cites W2099022345 @default.
• W2887016123 cites W2107797912 @default.
• W2887016123 cites W2110401890 @default.
• W2887016123 cites W2140501627 @default.
• W2887016123 cites W2143342727 @default.
• W2887016123 cites W2161055506 @default.
• W2887016123 cites W2165637474 @default.
• W2887016123 cites W2169387542 @default.
• W2887016123 cites W2170312517 @default.
• W2887016123 doi "https://doi.org/10.1161/circinterventions.111.965608" @default.
• W2887016123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22619259" @default.
• W2887016123 hasPublicationYear "2012" @default.
• W2887016123 type Work @default.
• W2887016123 sameAs 2887016123 @default.
• W2887016123 citedByCount "32" @default.
• W2887016123 countsByYear W28870161232012 @default.
• W2887016123 countsByYear W28870161232013 @default.
• W2887016123 countsByYear W28870161232014 @default.
• W2887016123 countsByYear W28870161232015 @default.
• W2887016123 countsByYear W28870161232016 @default.
• W2887016123 countsByYear W28870161232017 @default.
• W2887016123 countsByYear W28870161232018 @default.
• W2887016123 countsByYear W28870161232019 @default.
• W2887016123 countsByYear W28870161232020 @default.
• W2887016123 countsByYear W28870161232021 @default.
• W2887016123 countsByYear W28870161232022 @default.
• W2887016123 crossrefType "journal-article" @default.
• W2887016123 hasAuthorship W2887016123A5000539924 @default.
• W2887016123 hasAuthorship W2887016123A5012918602 @default.
• W2887016123 hasAuthorship W2887016123A5012980712 @default.
• W2887016123 hasAuthorship W2887016123A5018963320 @default.
• W2887016123 hasAuthorship W2887016123A5023563685 @default.
• W2887016123 hasAuthorship W2887016123A5027684606 @default.
• W2887016123 hasAuthorship W2887016123A5030427600 @default.
• W2887016123 hasAuthorship W2887016123A5033408468 @default.
• W2887016123 hasAuthorship W2887016123A5034363730 @default.
• W2887016123 hasAuthorship W2887016123A5040418600 @default.
• W2887016123 hasAuthorship W2887016123A5043398153 @default.
• W2887016123 hasAuthorship W2887016123A5054604221 @default.
• W2887016123 hasAuthorship W2887016123A5060370891 @default.
• W2887016123 hasAuthorship W2887016123A5065650208 @default.
• W2887016123 hasAuthorship W2887016123A5068846586 @default.
• W2887016123 hasAuthorship W2887016123A5070006952 @default.
• W2887016123 hasAuthorship W2887016123A5085097521 @default.
• W2887016123 hasAuthorship W2887016123A5087089751 @default.
• W2887016123 hasBestOaLocation W28870161231 @default.
• W2887016123 hasConcept C111113717 @default.
• W2887016123 hasConcept C112705442 @default.
• W2887016123 hasConcept C126322002 @default.
• W2887016123 hasConcept C197934379 @default.
• W2887016123 hasConcept C2777056448 @default.
• W2887016123 hasConcept C2777288759 @default.
• W2887016123 hasConcept C2777628954 @default.
• W2887016123 hasConcept C2777849778 @default.
• W2887016123 hasConcept C2778375690 @default.
• W2887016123 hasConcept C2780400711 @default.
• W2887016123 hasConcept C27924281 @default.
• W2887016123 hasConcept C35294091 @default.
• W2887016123 hasConcept C42219234 @default.
• W2887016123 hasConcept C45393284 @default.
• W2887016123 hasConcept C500558357 @default.
• W2887016123 hasConcept C71924100 @default.

• next